Abciximab biosimilar (ISU Abxis) | Interleukin Related interleukin-related.com

Product Name :
Abciximab biosimilar (ISU Abxis)

Search keywords :
Abciximab

drugId :
null

Target Vo:
Integrin alpha-IIb/beta-3

Target Vo Short Name :
GP IIb/IIIa

Moa_Name:
Integrin alpha-IIb/beta-3 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Isu Abxis Co Ltd

Active Company_Name :
Isu Abxis Co Ltd

Active Indication_Name:
Myocardial Ischemia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bax Antibody (YA591)
FosB Antibody
CD8 alpha Antibody: CD8 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to CD8 alpha. It can be used for WB,IHC-P assays with tag free, in the background of Human, Hamster.

Author: Interleukin Related

Related Posts